Skip to main content
All lobbying filings

VAN SCOYOC ASSOCIATES

VAN SCOYOC ASSOCIATES filed a Q4 report for NMDP on January 20, 2026, reporting $120,000 in lobbying income.

Lobbying for NMDP · Nonprofit organization that operates Be The Match Registry

All filings by VAN SCOYOC ASSOCIATES · Everything NMDP has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$120,000
What the client paid this registrant for the period.
Client based in
Minnesota

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 6

Monitor Transplant courier policy related issues

Monitor Donor recruitment and transplant services, as follows: H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Monitor H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026, Donor recruitment and transplant services

H.R.5160, Stem Cell Therapeutic and Research Reauthorization Act of 2025, Cellular Transplant related issues and initiatives; and Reauthorization related issues Monitor the following: Transplant courier issues FDA, Laboratory Developed Tests Rule VALID Act, Laboratory developed issues Public Law 119-21, One Big Beautiful Bill Act, Health care coverage related issues

Monitor Transplant courier issues

Life Saving Leave Act, Entirety

 Bills named in this filing 5
  • H.R. 4016
    Department of Defense Appropriations Act, 2026
  • S. 2572
    Department of Defense Appropriations Act, 2026
  • H.R. 5304
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
  • S. 2587
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
  • H.R. 5160
    Stem Cell Therapeutic and Research Reauthorization Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem